L

LUX Infusion

Outpatient infusion centers for IV therapies

Pharmacy Manager

Full-TimeUpdated on 10/23/2026
$140k - $170k
Mid
Bachelor's, PhD
Belleville, IL, USA
In PersonExpected to work on-site in Belleville, IL; travel up to 10% and occasional overnight travel are required.
Medical, Clinical & VeterinaryPharmacy

About the job

Requirements
  • Graduate from an ACPE-accredited School of Pharmacy with at least a BS pharmacy degree; a Doctorate in pharmacy is preferred.
  • Have at least three years of required experience in home infusion therapy or specialty pharmacy, or at least three years of clinical hospital experience in compounding, transplant, Hepatitis C, hemophilia, multiple sclerosis, rheumatoid arthritis or psoriasis, Crohn’s disease or ulcerative colitis, nutritional support, oncology, or infectious disease.
  • Hold a current, unrestricted pharmacist license in good standing from the Board of Pharmacy, minimally in the state(s) where the pharmacy is licensed.
  • Have experience providing customer service to internal and external customers, meeting service quality standards, and evaluating customer satisfaction.
  • Have intermediate-level skills in Microsoft Office, including Word, Excel, and PowerPoint.
  • Be willing to travel up to 10% for business purposes when necessary, such as meetings, conferences, or seminars.
  • Know the principles and practices of prescription compounding and dispensing.
  • Know pharmacy, drug, narcotic, and related state board laws and regulations, prescription monitoring programs, federal laws, and accreditation standards.
  • Know pharmaceuticals, drugs, narcotics, and poisons.
  • Know dose calculations and the preparation and use of percentage and stock solutions.
  • Know the basic sciences underlying pharmacy, including chemistry, biology, and physics.
  • Know the processes involved in manufacturing pharmaceutical preparations.
  • Know stock control and related record keeping.
  • Know USP 795, USP 797, and USP 800, as applicable.
  • Be able to apply safety and efficiency in prescribing, dispensing, administering, and using drugs and related articles for illness prevention and health management.
  • Be able to fill prescriptions and prepare official drugs and standard medications.
  • Be able to recognize physical, chemical, and therapeutic incompatibilities.
  • Be able to analyze and understand oral or written orders from physicians or other recognized medical personnel, including standard symbols and terminology.
  • Be able to apply pharmaceutical laboratory techniques.
  • Be able to maintain accurate records and prepare work-related reports and correspondence.
  • Be able to organize and coordinate the work of others and set priorities and assign work to other professionals.
  • Be able to prioritize and handle multiple tasks and projects concurrently, maintain scheduling flexibility, work overtime, and provide on-call coverage.
  • Have careful attention to detail.
  • Be able to communicate actively, inspire and motivate staff, think and act strategically and proactively, and maintain favorable public relations.
  • Have strong verbal, written, and communication skills, group presentation skills, and analytical skills.
  • Become and remain proficient in all programs necessary to execute the role.
  • Participate annually in required legal and ethical compliance training and comply with LUX Infusion's legal, ethical, and compliance policies and procedures.
  • Assist directly or coordinate appropriate assistance to ensure access to LUX Infusion services for individuals with disabilities, as required.
Responsibilities
  • Provide safe and appropriate pharmacy services to patients in accordance with company policies and procedures, professional standards, and applicable state and regulatory requirements.
  • Serve as Pharmacist in Charge for the licensed location and register with the Board of Pharmacy for applicable states where the pharmacy serves patients.
  • Perform distributive and clinical pharmacy activities and related services to support quality patient care.
  • Assist with daily pharmacy staff operations, overseeing prescription processing, clinical assessment, drug utilization review, prescription verification, product labeling, and fulfillment.
  • Support product procurement and inventory management at the pharmacy location and perform additional pharmacy-operation and patient-service duties as assigned by leadership.
  • Assist pharmacy leadership in maintaining company policies, procedures, and standards established by accrediting bodies, State Boards of Pharmacy, and other authorities.
  • Assist pharmacy leadership with Performance Improvement/Quality Management Committee and Clinical Oversight Committee requirements, including data gathering, report generation, and corrective actions.
  • Oversee and supervise pharmacy personnel to ensure safe and effective pharmacy operations.
  • Set the tone for pharmacy operations, develop and support the workplace culture, and ensure opportunities for team professional development.
  • Communicate leadership-provided information about people, process, and technology updates to the pharmacy operations team.
  • Direct, coordinate, and evaluate pharmacy staff; interview, hire, and train employees; plan, assign, and direct work; appraise performance; plan succession; reward and discipline employees; address complaints; and resolve problems in accordance with organizational policies and applicable laws.
  • Use prescription-volume data and available resources to meet volume expectations and communicate needs to the team to achieve daily, weekly, monthly, and quarterly goals.
  • Maintain required out-of-state nonresident pharmacy licenses, including nonresident, DEA, controlled-substance, and sterile-compounding licenses, as required for the pharmacy operation.
  • Conduct initial patient evaluations and reassessments, collecting, analyzing, interpreting, and evaluating data about drug therapy needs, interactions, unusual doses, allergies, adverse reactions or side effects, response to therapy, and compliance.
  • Obtain patient clinical and prescription history and use clinical knowledge, systems, and tools to optimize drug therapy management.
  • Collaborate with patients’ prescribers and care teams to support therapeutic objectives, monitor treatment response, and design and use appropriate drug therapy management.
  • Interpret data to objectively assess physiological functions and monitor drug therapy effects, as applicable.
  • Evaluate signs or symptoms related to disease progression, recommend drug therapy modifications, and engage prescribers and care teams as needed to help prevent problems.
  • Assist referring physicians and institutions in planning and implementing patient care transitions from hospital to home, as applicable.
  • Assist home patients in self-managing home infusion and specialty pharmacy therapy, as applicable.
  • Conduct patient calls to perform required assessments throughout treatment plans in support of accreditation, insurance-provider, and manufacturer-contract requirements.
  • Counsel patients, family members, and healthcare professionals and answer questions about drug therapy.
  • Assist in evaluating and supporting patient issues arising from psychological, social, and economic aspects of therapies.
  • Document all communications and telephone contacts with patients and physicians thoroughly and appropriately in patient medical records.
  • Prepare progress reports for referring physicians, insurance providers, and others as needed.
  • Supervise or directly compound and dispense pharmaceuticals and ancillary supplies in accordance with federal, state, and local laws and professional standards.
  • Process and check medications, supplies, and equipment before dispensing.
  • Assist with purchasing, receiving, inventory, and storage of pharmaceuticals.
  • Assist with special projects and clinical research as directed.
  • Maintain proficiency in home infusion and specialty pharmacy skills and theory by reviewing literature and attending in-services, seminars, and conferences.
  • Participate in the on-call rotation, quality assurance activities, and audits as directed.
  • Ensure compliance with state and federal regulations, accrediting-body standards, corporate policies, and performance standards.
  • Work with staff to develop and implement ideas for delivering high-quality, cost-effective services; this performance-improvement work may comprise up to 10% of the job.
  • Maintain and support pharmacy-location operations as applicable, including daily pharmacy statistics, cleanroom maintenance and oversight, delivery and shipment confirmations, Prescription Monitoring Program reporting, month-end inventory and staff activities, month-end reporting with finance, and mandatory in-service tracking.
  • Manage employee evaluations and reviews.
  • Participate in professional societies and organizations.
  • Perform related duties as requested.
  • Deliver clear oral communication, listen and seek clarification, respond to questions, participate in meetings, and present to groups.
  • Write clearly and informatively, edit for spelling and grammar, adapt writing style to needs, present numerical data effectively, and read and interpret written information.
Desired Qualifications
  • At least three years of experience at a manager or supervisory level overseeing pharmacy operations team members or equivalent clinical resources.
  • Experience and knowledge of accreditation requirements and processes for specialty or infusion pharmacies.
  • General understanding of pharmacy and medical reimbursement concepts and their applicability to prescription profitability.
  • General understanding of pharmacy inventory management and reconciliation processes.
  • General understanding of wholesaler, supplier, and distributor relationships, contractual agreements, and processes needed to access products in a pharmacy environment.
  • Experience and knowledge of 340B program requirements, practices, and reporting needs for contracted healthcare institutions and participating entities.

About the company

LUX Infusion provides ambulatory infusion services in Alaska, delivering IV and injectable therapies outside hospital settings in spa-like centers in Anchorage, Palmer, and Fairbanks. A clinical team of physicians, nurse practitioners, and infusion nurses collaborates with referring providers, while centers handle pre-authorizations and financial assistance, serving patients with private insurance, Medicare, and Medicaid. In 2025, LUX Infusion was acquired by BioMatrix Infusion Pharmacy, integrating its care teams into a national ambulatory infusion network to expand the Pacific Northwest and accelerate growth; the company holds NICA accreditation and the AICE-Ambulatory Infusion Center of Excellence designation. Its goal is to provide high-quality, patient-centered outpatient infusion care that reduces medical costs and offers an alternative to hospital-based treatment.

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

Anchorage, Alaska

Founded

2022

Get referred to LUX Infusion

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 6, 2026 Infuse IQ acquisition adds Wyoming sites and widens referral reach.
  • May 28, 2026 promotion of Dan Teich strengthens market-access negotiations with payors and manufacturers.
  • Home infusion plus ambulatory care creates cross-referral opportunities and more therapy starts than hospital sites.

What critics are saying

  • Biomatrix integration can standardize LUX away, erasing local brand distinction by 2027.
  • Infuse IQ’s August 6, 2026 acquisition stretches management and capital across Wyoming and Alaska.
  • Specialty infusion reimbursement pressure from payors and manufacturers can compress margins if contracts reset in 2027.

What makes LUX Infusion unique

  • Alaska’s only scaled ambulatory infusion footprint in Anchorage, Palmer, and Fairbanks anchors local density.
  • Clinician-led, spa-like infusion centers with NICA and AICE designations signal differentiated patient experience.
  • BioMatrix acquired LUX on October 17, 2025, plugging it into national specialty-infusion infrastructure.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options

Company News

PR Newswire
Oct 15th, 2026
LUX Infusion enters Colorado with acquisition of Loveland-based Suite Health

LUX Infusion, a clinician-led infusion services company based in Plantation, Florida, has acquired Suite Health, a specialty infusion therapy provider in Loveland, Colorado. The deal, announced October 15, 2026, marks LUX Infusion's entry into Colorado. Suite Health's local clinical team is known for patient support and responsive referral coordination. LUX Infusion will add clinical, operational, and technological resources while keeping Suite Health's personalised approach. "Our role is to build on that foundation," said Ted Kramm, chief executive officer of LUX Infusion. He said the aim is to make it easier for more patients to access infusion care in the setting that suits them best. LUX Infusion is a portfolio company of Frazier Healthcare Partners. The source gave no financial terms.

PR Newswire
Oct 9th, 2026
LUX Infusion adds Qfitlia to hemophilia treatment portfolio, expanding access for patients 12 and older

LUX Infusion, a US-based clinician-led infusion service network, announced it is now authorised to dispense Qfitlia (fitusiran), expanding access to hemophilia treatment. The subcutaneous therapy is for patients aged 12 and older with hemophilia A or B, with or without Factor VIII or IX inhibitors, requiring routine bleed prevention treatment. The company provides comprehensive support throughout the treatment process, including benefit navigation and 24/7 on-call guidance. LUX Infusion pairs each patient with a dedicated contact who has bleeding disorder experience and works closely with Hemophilia Treatment Centers. "Adding Qfitlia to our portfolio enables us to offer a unique treatment option that is fully supported by our high-touch model," said Ted Kramm, chief executive officer of LUX Infusion.

Access Market Intelligence
Aug 30th, 2026
Specialty Pharmacy news roundup: august 2026.

Specialty Pharmacy news roundup: august 2026. The following are just a few of the many recent specialty pharmacy activities during the past month. Biologics by McKesson, an independent specialty pharmacy specializing in oncology, cell and gene, and rare disease therapies, has been selected by Cycle Pharmaceuticals as a limited distribution specialty pharmacy provider for CAVHANZA (nilotinib) Orally Disintegrating Tablets. CAVHANZA is a tyrosine kinase inhibitor indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase; and/or adult patients with chronic phase (CP) and accelerated phase (AP) Ph+ CML resistant to or intolerant to prior therapy that included imatinib. Biologics by McKesson has also been selected by Revolution Medicines as a specialty pharmacy provider for RASONQUE (daraxonrasib) within its distribution network. RASONQUE is an oral therapy approved for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy. Carepoint Pharmacy, an end-to-end access hub and dispensing pharmacy serving patients nationwide, announced a new partnership with and investment from New Heritage Capital, a Boston-based private equity firm focused on partnering with high-growth, founder-owned businesses. The investment was structured using Heritage's Private IPO solution, which leaves operating control in the hands of current Carepoint management while providing the financial flexibility to accelerate future growth. LUX Infusion, a clinician-led infusion services company, announced the acquisition of Infuse IQ, a trusted Wyoming-headquartered independent infusion therapy provider delivering safe, personalized infusion and injection treatments across a broad range of medical specialties. The acquisition expands LUX Infusion's ambulatory infusion network and strengthens its ability to serve patients and referring providers in communities across the country. Onco360, the nation's leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Rigel Pharmaceuticals for VEPPANU (vepdegestrant), which is indicated for the treatment of adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor-1 (ESR1)-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy. Onco360 has also been selected as a pharmacy partner by Revolution Medicines for RASONQUE (daraxonrasib), which is an inhibitor of the RAS GTPase family, indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy. PANTHERx Rare has been selected by Intercept Pharmaceuticals, Inc., a wholly owned subsidiary of Alfasigma S.p.A., as the exclusive U.S. specialty pharmacy partner to distribute LYNAVOY (linerixibat), the first FDA-approved treatment specifically indicated for cholestatic pruritus in adults with primary biliary cholangitis (PBC). This collaboration underscores the company's commitment to innovative rare disease care and its mission to reduce barriers for patients facing complex conditions. PANTHERx Rare has also been selected by Vera Therapeutics, Inc. to dispense TRUTAKNA (atacicept-vymj), an FDA-approved treatment indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of disease progression. IgAN is a complex, progressive kidney disease, and timely access to treatment can make a meaningful difference. The company's team is committed to helping patients navigate access, stay on therapy, and receive personalized support every step of the way. You can find even more news and insights by subscribing to AMI's Specialty Pharmacy Database. Keep up with accreditations earned, key decision-maker changes, mergers and acquisitions and MORE.

PR Newswire
Aug 6th, 2026
LUX Infusion Acquires Infuse IQ, Expanding Its National Ambulatory Infusion Footprint

/PRNewswire/ -- LUX Infusion, a clinician-led infusion services company, today announced the acquisition of Infuse IQ, a trusted Wyoming-headquartered...

LUX Infusion
May 28th, 2026
LUX Infusion promotes Dan Teich to Senior Vice President, Market Access.

LUX Infusion promotes Dan Teich to Senior Vice President, Market Access. Unified leadership role aligns trade relations and managed care to strengthen distribution, manufacturer, and payor partnerships. [Plantation, FL] - May 28, 2026 - LUX Infusion, a U.S.-based, clinician-led infusion services company, today announced the promotion of Dan Teich to Senior Vice President, Market Access. In this expanded role, Teich will lead a unified market access function that brings together the company's trade relations and managed care operations under a single, cohesive strategy designed to deepen alignment with LUX Infusion's distribution, manufacturer, and payor partners. "Dan has been an exceptional leader in shaping our trade relationships, and this promotion reflects both his contributions and our confidence in his vision," said Ted Kramm, Chief Executive Officer of LUX Infusion. "By unifying trade relations and managed care under his leadership, we are creating a more integrated approach to how we work with our partners, positioning LUX Infusion to deliver greater value across the entire specialty infusion ecosystem." As SVP, Market Access, Teich will be responsible for developing and executing a comprehensive strategy that aligns the company's market access partnerships across pharmaceutical manufacturers, specialty distributors, group purchasing organizations, and health plan payors with LUX Infusion's mission to expand patient access to high-quality, accessible infusion care. Teich brings more than 15 years of expertise in pharmacy operations, supply chain management, contract negotiation, and executive leadership across the specialty infusion, health system, and retail pharmacy sectors. Prior to joining LUX Infusion, he served as Vice President of Health Systems Manufacturer Relations at Cencora (formerly AmerisourceBergen), where he led negotiations of specialty and biosimilar GPO contracts for health systems, consistently exceeding fiscal-year performance targets. Before Cencora, Teich served as Vice President of Pharmacy Purchasing and Contracting at M Health Fairview, overseeing nearly $1 billion in annual drug spend and driving significant margin improvements through strategic contracting. As Program Manager of Home Infusion and Compounding at the same organization, he grew home infusion revenue by more than 240% over four years. He also held leadership roles at PharMerica and Walgreens. Teich holds a Doctor of Pharmacy (Pharm.D.) from North Dakota State University and has been a licensed pharmacist in Minnesota since 2007. "The convergence of trade relations and managed care under a unified market access function is a natural evolution for LUX Infusion as we scale nationally," said Teich. "I'm energized by the opportunity to work even more closely with our manufacturer, distribution, and payor partners to remove barriers and ensure patients receive the therapies they need, when and where they need them." This leadership structure reflects LUX Infusion's broader commitment to building a fully integrated infusion services platform that leverages strong partner relationships to drive superior clinical outcomes, operational efficiency, and expanded patient access as the company continues its growth toward more than 50 infusion locations nationwide. About LUX Infusion. LUX Infusion is elevating infusions into an experience. As a U.S. based, clinician-led infusion services company, it provides both home infusion and ambulatory infusion center services, bringing clarity, compassion, and expertise to every patient relationship. With faster therapy starts, dedicated patient support, and continuous data sharing with providers, LUX Infusion ensures patients feel supported, and providers and partners can trust in better adherence and outcomes. Media Contact: Tara Marchese Senior Director of Marketing, LUX Infusion Tel: 954-908-7636 Email: [email protected]